CurrentUnitedHealthcarePolicy CS169NE.E

Gastrointestinal Pathogen Testing Infectious Diarrhea Ne Cs

Defines coverage criteria for multiplex PCR gastrointestinal pathogen panel testing in Nebraska, specifying when panels with up to 5 targets or up to 11 targets are considered proven and medically necessary, and declares panels for other indications or >11 targets as not medically necessary.

Policy Summary

PayerUnitedHealthcare

PolicyGastrointestinal Pathogen Testing Infectious Diarrhea Ne Cs

Policy CodePolicy CS169NE.E

Change TypeNo material change

Effective DateFeb 1, 2026

Next Review Date

Key ActionDocument medical necessity fully in the patient record (history, exam, diagnostic results) as it may be required for review.

SourceLink

POLICY UPDATE CHANGES

No material clinical/coverage changes — the policy has no listed changes.

2Allowed Panel Sizes (3-5, 6-11 targets)

1Not covered: >11 targets

1Jurisdiction (Nebraska)

Coverage Summary

Scope: Defines coverage criteria for multiplex PCR gastrointestinal pathogen panel testing in Nebraska, specifying when panels with up to 5 targets or up to 11 targets are considered proven and medically necessary. Policy Number: CS169NE.E. Jurisdiction: Nebraska. Effective Date: February 1, 2026.

Medical Necessity Criteria

Proven and Medically Necessary

Covered when ALL of the following are met:

ALL of the following

ALL of the following
- AND the individual has any one of
  - Diarrhea for more than 7 days> 7 days
  - Diarrhea with at least one of the following: Fever; Bloody or mucoid stools; Severe abdominal cramping or tenderness; Signs of sepsis
    The list inside this node represents OR among those symptoms
  - Suspected enteric fever (typhoid, paratyphoid) in an individual with a history of recent travel to an endemic region or who has consumed foods prepared by people with recent endemic exposure
    Examples of endemic regions: South Central Asia, Southeast Asia, Southern Africa

refvenience_note_mod_removed_in_specification_do_not_use_this_field_reflection_but_required_by_schema_unused_field_please_ignore_reflection_placeholder_when_parsing_the_output_reasoning_only_field_ref_should_be_echoed_below_ref_not_present_in_nodes_object_for_parity_with_consumer_parsing_requirements_but_must_be_in_top_level_object_named_ref_field_instead_of_nodes_objects_ref_field_is_provided_outside_nodes_block_in_this_object_for_schema_compliance_and_to_match_user_request_consistency_please_ignore_this_long_note_and_parse_ref_field_normally_instead_of_this_note_field_which_is_intentional_placeholder

refTitle_placeholder_unused_ignore_for_parsing_purpose_only_ref_field_below_is_authoritative

ref_html_unused_ignore

refTitle_unused_ignore

ref_used_for_echo_below_that_must_match_request

Proven and Medically Necessary — Persistent Diarrhea / Up to 11 targets

Covered when ALL of the following are met:

ALL of the following

ALL of the following
- AND the individual is
  - ALL of the following
    Diarrhea for more than 7 days> 7 days
    Diarrhea with at least one of: Fever; Bloody or mucoid stools; Severe abdominal cramping or tenderness; Signs of sepsis
    OR among these signs/symptoms

refTitle_placeholder_unused_ignore_for_parsing_purpose_only_ref_field_below_is_authoritative

Instructions / Special Circumstances

ALL of the following

Other condition causing immunosuppression and other stool diagnostic studies have failed to yield a pathogenic organism
Listed under "Instructions for Use" as an indication

refTitle_placeholder_unused_ignore_for_parsing_purpose_only_ref_field_below_is_authoritative

ref_used_for_echo_below_that_must_match_request

Unproven and Not Medically Necessary

Not covered when ANY of the following apply:

ANY of the following

Multiplex PCR panel testing for gastrointestinal pathogens for all other indications (i.e., indications not specified as proven/medically necessary above)
Multiplex PCR panel testing for gastrointestinal pathogens with > 11 targets

refTitle_placeholder_unused_ignore_for_parsing_purpose_only_ref_field_below_is_authoritative

ref_used_for_echo_below_that_must_match_request

Provider Actions & Billing

Documentation Required

Support medical necessity in medical record

Document in the patient's medical record the clinical information that supports medical necessity (relevant history, physical exam findings, and pertinent diagnostic test results). This documentation should be legible, maintained in the record, and may be required for review.

Documentation may be required for review to assess whether the member meets clinical criteria for coverage.

Billing Rule

Use appropriate CPT code by target count

Report the CPT code that corresponds to the number of targets included in the gastrointestinal pathogen panel.

87505 = 3-5 targets
87506 = 6-11 targets
87507 = 12-25 targets

Denial conditions: Multiplex PCR panel testing for gastrointestinal pathogens is not covered for indications other than those specified as proven/medically necessary in the policy and testing with more than 11 targets is not medically necessary.

Clinical and billing implications: The panels do not routinely provide antibiotic susceptibility or subtyping needed for public health surveillance; they can detect nucleic acid from nonviable organisms, which may complicate result interpretation. Due to these limitations and the policy rules, tests ordered outside covered indications or with >11 targets may be denied for payment.

Background & Evidence

Multiplex PCR panel characteristics: These assays detect multiple bacterial, viral, protozoal, and parasitic enteropathogens simultaneously and generally offer higher sensitivity and faster turnaround compared with culture. They use various molecular techniques (real-time PCR, endpoint PCR with microfluidics/array technologies, and integrated platforms) and are increasingly used in place of traditional methods when pathogen testing is indicated.

Limitations: Multiplex molecular panels may not yield antibiotic susceptibility or allow reliable subtyping for some organisms, and they can detect nucleic acid from nonviable organisms, which limits their use as tests of cure and can complicate clinical interpretation.

Recommended selective use contexts: Per guidelines and the policy, multiplex panels are recommended selectively for individuals with moderate to severe, bloody, febrile, dysenteric, nosocomial, or persistent diarrhea and for immunocompromised patients. For persistent diarrhea, testing for parasites should be considered when diarrhea lasts > 7 days, but panels may be limited for parasitic detection. Viral-targeting panels have limited routine usefulness except in immunocompromised hosts or for infection control purposes.

Systematic reviews citedPatel et al. (2024), López Muñoz (2024), Chang et al. (2021), Meyer et al. (2020)

Term	Definition
Persistent diarrhea
Diarrhea lasting more than 7 days (as used in coverage criteria).
Suspected enteric fever
Clinical suspicion of typhoid or paratyphoid associated with recent travel to endemic areas or exposure to food handlers from endemic regions.

OpenPayer

Gastrointestinal Pathogen Testing Infectious Diarrhea Ne Cs

Coverage Summary

Medical Necessity Criteria

Coding

Provider Actions & Billing

Background & Evidence

Revision History

87505	Infectious agent detection by nucleic acid; gastrointestinal pathogen, 3-5 targets
87506	Infectious agent detection by nucleic acid; gastrointestinal pathogen, 6-11 targets
87507	Infectious agent detection by nucleic acid; gastrointestinal pathogen, 12-25 targets